insights_auto
Why is GANX down 9.60%?
Dive Deeperchevron_right
GANX:NASDAQ
Gain Therapeutics Inc
US$0.94
arrow_downward
-9.60%(-0.100) 1D
US$0.95
arrow_upward
+1.10% (+0.010)todayPre-market
Closed: ኖቬም 16, 4:00:01 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GANX...
Open
US$1.01
High
US$1.08
Low
US$0.94
Mkt. cap
41.86 ሚ
Avg. vol.
527.99 ሺ
Volume
11.40 ሺ
52-wk high
US$4.34
52-wk low
US$0.94
EPS
-US$0.43
Beta
0.29
Shares outstanding
44.52 ሚ
No. of employees
21
Open
US$1.01
High
US$1.08
Low
US$0.94
Mkt. cap
41.86 ሚ
Avg. vol.
527.99 ሺ
Volume
11.40 ሺ
52-wk high
US$4.34
52-wk low
US$0.94
EPS
-US$0.43
Beta
0.29
Shares outstanding
44.52 ሚ
No. of employees
21
News stories
From web sources and news partners
Zacks
·
ከ19 ሰዓቶች በፊት
Gain Therapeutics (GANX) Upgraded to Buy: Here's What You Should Know
About Gain Therapeutics Inc
CEO-
Employees21
Founded2017
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitegaintherapeutics.com